Prime Medicine (PRME) Tax Provisions (2021 - 2024)
Prime Medicine (PRME) reported Tax Provisions of -$134000.0 for Q2 2024, down 532.26% on a YoY basis from $31000.0 in Q3 2023, and down 200.0% quarter-over-quarter from $134000.0 in Q1 2024.
Prime Medicine (PRME) Tax Provisions (2021 - 2024) Analysis & Trends
Prime Medicine has reported Tax Provisions for 4 years, with the latest figure at -$134000.0 in Q2 2024.
- For the quarter ending Q2 2024, Tax Provisions fell 532.26% year-over-year to -$134000.0; the trailing twelve-month figure through Mar 2025 stood at -$134000.0 (down 335.09% YoY), and the FY2023 full-year result was -$279000.0, up 70.57% from the prior year.
- Tax Provisions for Q2 2024 stood at -$134000.0, down from $134000.0 in the prior quarter.
- The five-year high for Tax Provisions was $1.4 million in Q4 2021, with the low at -$2.4 million in Q3 2021.
- Historically, Tax Provisions has averaged -$202727.3 across 4 years, with a median of -$134000.0 in 2024.
- The largest YoY upside for Tax Provisions was 166.34% in 2024 against a maximum downside of 532.26% in 2024.
- Prime Medicine's Tax Provisions stood at $1.4 million in 2021, then plunged by 113.61% to -$186000.0 in 2022, then jumped by 41.94% to -$108000.0 in 2023, then decreased by 24.07% to -$134000.0 in 2024.
- The last three Tax Provisions figures came in at -$134000.0 (Q2 2024), $134000.0 (Q1 2024), and -$108000.0 (Q3 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Prime Medicine | 572.02 Mn | 572.02 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -134,000.00 |
| Mar 31, 2024 | 134,000.00 |
| Sep 30, 2023 | -108,000.00 |
| Jun 30, 2023 | 31,000.00 |
| Mar 31, 2023 | -202,000.00 |
| Dec 31, 2022 | -186,000.00 |
| Sep 30, 2022 | 212,000.00 |
| Jun 30, 2022 | -442,000.00 |
| Mar 31, 2022 | -532,000.00 |
| Dec 31, 2021 | 1.37 Mn |
| Sep 30, 2021 | -2.37 Mn |